Baidu
map

感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗

2020-09-08 美国感染病学会 IDSA官网

抗生素耐药

2020年9月，美国感染病学会(IDSA)发布了抗生素耐药性革兰氏阴性菌感染的治疗指南，抗菌素耐药性上升依然是全球性的问题，临床选择有效抗生素治疗耐药病原体感染充满挑战。该指南主要涉及产超广谱&bet

中文标题：

2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗

英文标题：

Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections

发布机构：

美国感染病学会

发布日期：

2020-09-08

简要介绍：

2020年9月，美国感染病学会(IDSA)发布了抗生素耐药性革兰氏阴性菌感染的治疗指南，抗菌素耐药性上升依然是全球性的问题，临床选择有效抗生素治疗耐药病原体感染充满挑战。该指南主要涉及产超广谱β内酰胺酶肠杆菌 (ESBL-E)，耐碳青霉烯类肠杆菌(CRE) 以及难治耐药性(DTR)铜绿假单胞菌的治疗。此外还介绍了新型抗生素，如头孢洛扎-他唑巴坦，头孢他啶-阿维巴坦，亚胺培南-雷巴坦，美罗培南-法硼巴坦，头孢地尔的应用。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4e5a01c0020026ac, title=2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗, enTitle=Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections, guiderFrom=IDSA官网, authorId=0, author=, summary=2020年9月，美国感染病学会(IDSA)发布了抗生素耐药性革兰氏阴性菌感染的治疗指南，抗菌素耐药性上升依然是全球性的问题，临床选择有效抗生素治疗耐药病原体感染充满挑战。该指南主要涉及产超广谱&bet, cover=https://img.medsci.cn/20201031/1604075336250_2020535.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会（IDSA）是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是：为临床增加可靠性证据，促进分享以减少传染病给社会带来的经济负担，促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Tue Sep 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年9月，美国感染病学会(IDSA)发布了抗生素耐药性革兰氏阴性菌感染的治疗指南，抗菌素耐药性上升依然是全球性的问题，临床选择有效抗生素治疗耐药病原体感染充满挑战。该指南主要涉及产超广谱&beta;内酰胺酶肠杆菌 (ESBL-E)，耐碳青霉烯类肠杆菌(CRE) 以及难治耐药性(DTR)铜绿假单胞菌的治疗。此外还介绍了新型抗生素，如头孢洛扎-他唑巴坦，头孢他啶-阿维巴坦，亚胺培南-雷巴坦，美罗培南-法硼巴坦，头孢地尔的应用。</p> </div> </div> </div>, tagList=[TagDto(tagId=12426, tagName=抗生素耐药)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12426, guiderKeyword=抗生素耐药, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6399, appHits=603, showAppHits=0, pcHits=2358, showPcHits=5796, likes=0, shares=30, comments=18, approvalStatus=1, publishedTime=Sat Oct 31 00:51:53 CST 2020, publishedTimeString=2020-09-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 00:29:02 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:05:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗.pdf)])
2020 IDSA指南：抗生素耐药性革兰氏阴性菌感染的治疗.pdf
下载请点击：
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192357, encodeId=11ed119235ef0, content=非常详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f865475954, createdName=ms3000001627599051, createdTime=Fri Feb 11 15:49:48 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074598, encodeId=d30110e4598b0, content=学习了，挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:18:19 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074257, encodeId=9d6510e4257a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9c41569795, createdName=xiangguo2008, createdTime=Fri Nov 26 15:30:39 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064213, encodeId=c3c8106421385, content= 有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca5648976, createdName=ms2000001094763409, createdTime=Tue Oct 26 23:10:25 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058902, encodeId=0804105890211, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Sat Oct 09 11:28:06 CST 2021, time=2021-10-09, status=1, ipAttribution=)]
    2022-02-11 ms3000001627599051

    非常详细

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192357, encodeId=11ed119235ef0, content=非常详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f865475954, createdName=ms3000001627599051, createdTime=Fri Feb 11 15:49:48 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074598, encodeId=d30110e4598b0, content=学习了，挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:18:19 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074257, encodeId=9d6510e4257a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9c41569795, createdName=xiangguo2008, createdTime=Fri Nov 26 15:30:39 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064213, encodeId=c3c8106421385, content= 有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca5648976, createdName=ms2000001094763409, createdTime=Tue Oct 26 23:10:25 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058902, encodeId=0804105890211, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Sat Oct 09 11:28:06 CST 2021, time=2021-10-09, status=1, ipAttribution=)]
    2021-11-27 ms8000001755238620

    学习了，挺好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192357, encodeId=11ed119235ef0, content=非常详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f865475954, createdName=ms3000001627599051, createdTime=Fri Feb 11 15:49:48 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074598, encodeId=d30110e4598b0, content=学习了，挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:18:19 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074257, encodeId=9d6510e4257a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9c41569795, createdName=xiangguo2008, createdTime=Fri Nov 26 15:30:39 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064213, encodeId=c3c8106421385, content= 有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca5648976, createdName=ms2000001094763409, createdTime=Tue Oct 26 23:10:25 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058902, encodeId=0804105890211, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Sat Oct 09 11:28:06 CST 2021, time=2021-10-09, status=1, ipAttribution=)]
    2021-11-26 xiangguo2008

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1192357, encodeId=11ed119235ef0, content=非常详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f865475954, createdName=ms3000001627599051, createdTime=Fri Feb 11 15:49:48 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074598, encodeId=d30110e4598b0, content=学习了，挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:18:19 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074257, encodeId=9d6510e4257a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9c41569795, createdName=xiangguo2008, createdTime=Fri Nov 26 15:30:39 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064213, encodeId=c3c8106421385, content= 有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca5648976, createdName=ms2000001094763409, createdTime=Tue Oct 26 23:10:25 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058902, encodeId=0804105890211, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Sat Oct 09 11:28:06 CST 2021, time=2021-10-09, status=1, ipAttribution=)]
    2021-10-26 ms2000001094763409

    有中文版就更好了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1192357, encodeId=11ed119235ef0, content=非常详细, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f865475954, createdName=ms3000001627599051, createdTime=Fri Feb 11 15:49:48 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074598, encodeId=d30110e4598b0, content=学习了，挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14335617962, createdName=ms8000001755238620, createdTime=Sat Nov 27 20:18:19 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074257, encodeId=9d6510e4257a9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9c41569795, createdName=xiangguo2008, createdTime=Fri Nov 26 15:30:39 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064213, encodeId=c3c8106421385, content= 有中文版就更好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05ca5648976, createdName=ms2000001094763409, createdTime=Tue Oct 26 23:10:25 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058902, encodeId=0804105890211, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211204/b697f46076a04a549df4cf2e037f29fa/4d287437091e4aa7b707148db6d4fc52.jpg, createdBy=420a5575209, createdName=付星, createdTime=Sat Oct 09 11:28:06 CST 2021, time=2021-10-09, status=1, ipAttribution=)]
    2021-10-09 付星

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map